Under development, not yet for patient use. For multiple future benefits and highly relevant study endpoints. A positive correlation between technical features and beneficial outcomes has to be shown.
3328478 (EU, Granted)
19704221.1 (EU, Accepted)
10,806,902 (US, Granted)
16/966,546 (US, Accepted)
201980010557.4 (China, Granted)
2016299343 (Australia, Granted)
112018001895-3 (Brazil, Granted)
201817003681 (India, Granted)
PCT/EP2016/067785 (PCT) PCT/EP2019/051751 (PCT)
17/018,285 (US, Pending)
201680044512.5 (China, Pending)
2019215680 (Australia, Pending)
BR112020015371-0 (Brazil, Pending)
3,030,977 (Canada, Pending)
202037034867 (India, Pending)
2020-540538 (Japan, Pending)
2021-044347 (Japan, Pending)
10-2020-7024971 (South Korea, Pending)
10-2018-7005633 (South Korea, Pending)
3328478 (EU, Granted)
19704221.1 (EU, Accepted)
10,806,902 (US, Granted)
16/966,546 (US, Accepted)
201980010557.4 (China, Granted)
2016299343 (Australia, Granted)
112018001895-3 (Brazil, Granted)
201817003681 (India, Granted)
PCT/EP2016/067785 (PCT)
PCT/EP2019/051751 (PCT)
17/018,285 (US, Pending)
201680044512.5 (China, Pending)
2019215680 (Australia, Pending)
BR112020015371-0 (Brazil, Pending)
3,030,977 (Canada, Pending)
202037034867 (India, Pending)
2020-540538 (Japan, Pending)
2021-044347 (Japan, Pending)
10-2020-7024971 (South Korea, Pending)
10-2018-7005633 (South Korea, Pending)